课题基金 / 基金详情

MELANOMA GANGLIOSIDES AND INTEGRIN FUNCTION

MELANOMA GANGLIOSIDES AND INTEGRIN FUNCTION
黑色素瘤神经节苷脂和整合素功能
批准号:
2084218
负责人:
LELAND D POWELL
金额:
$7.55万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-07-01 至 1996-06-30

项目摘要

项目成果

LELAND D POWELL的其他基金

相似基金

相关文献

中文摘要
翻译
某些肿瘤,包括黑色素瘤和神经元肿瘤,以及 胚胎神经组织表达神经节苷脂(GD2、GD3和90AcGD3) 在正常成人组织中只有很低的水平,或者根本没有,这意味着 这些细胞和组织的表型特性。这个 建议的实验集中在理解某些生物学上 神经节苷脂在正常细胞和转化细胞中的作用(S)。许多研究 间接表明膜蛋白和蛋白质之间的相互作用 神经节苷脂确实存在于相同的双层中,并且这些 相互作用调节这些蛋白质的功能。建议数 实验直接探索这一概念,在两个独立但 互补的系统。第一个是基于其他人的工作表明 在黑色素瘤上发现的玻璃体连接素受体(VNR)与 细胞和某些黑色素瘤神经节苷脂。使用重塑的脂质体 从纯化的VNR和神经节苷脂出发,从功能和生化方面 将直接研究VNR-神经节苷脂联合作用。 实验方法,表达克隆技术将被用于 克隆神经节苷脂生物合成关键酶的基因。 然后,这些克隆将被用来操纵 细胞表面有不同的神经节苷脂。预期中的方法 需要从只表达简单神经节苷脂的细胞系开始 结构,然后用编码该基因的cdna 糖基转移酶(或控制它的调节蛋白S) 将糖渣附着到这个神经节苷脂上,构建下一个神经节苷脂 在生物合成途径中。在这种方式下,神经节苷脂的概况 单细胞系可以以迄今为止不可能的方式被操纵。 对细胞整合素分子(S)的功能研究将是 并与其神经节苷脂特征相关联。这些结果将 与所描述的体外重组系统直接可比 上面。这种一般的方法可以适用于广泛的研究 蛋白质。上面提到的三个神经节苷脂只是许多例子中的三个 发现糖脂和糖蛋白的异常糖基化 恶变。这些研究的长期目标是 了解酶的基础、调节和功能后果 这些变化,希望能更好地了解生物学 无论是正常组织还是恶性组织。
英文摘要
Certain tumors, including melanomas and neuronal tumors, as well as embryonic neural tissue, express gangliosides (GD2, GD3, and 9OAcGD3) found only in low levels, or not at all, in normal adult tissue, implying a role for them in the phenotypic properties of these cells and tissues. The experiments proposed are focused on understanding certain biological function(s) of gangliosides in normal and transformed cells. Many studies indirectly indicate that interactions between membrane proteins and gangliosides present in the same bilayer do occur, and that these interactions regulate the function of these proteins. The proposed experiments explore this concept directly in two independent but complementary systems. The first is based on the work of others indicating an association between the vitronectin receptor (VNr) found on melanoma cells and certain melanoma gangliosides. Using liposomes reconstituted from purified VNr and gangliosides, the functional and biochemical aspects of VNr-ganglioside association will be studied directly.In a parallel experimental approach, expression cloning techniques will be utilized to clone the cDNA's of key enzymes involved in ganglioside biosynthesis. These clones will then be utilized to manipulate the expression of different gangliosides on the cell's surface. The anticipated approach entails starting with a cell line which expresses only a simple ganglioside structure, and then transfection with the cDNA encoding for the glycosyltransferase (or regulatory protein(s) which control it) which attaches a sugar residue to this ganglioside, building the next ganglioside in the biosynthetic pathway. In this fashion, the ganglioside profile of a single cell line could be manipulated in a fashion heretofore not possible. Functional studies on the cell's integrin molecule(s) would then be performed and correlated with its ganglioside profile. These results would be directly comparable with the in vitro reconstituted system described above. This general approach can be adapted to the study a wide range of proteins.The three gangliosides noted above are just three of many examples of the aberrant glycosylation of glycolipids and glycoproteins found with malignant transformation. The longterm objectives of these studies is understanding the enzymatic basis, regulation, and functional consequences of these changes, with the hope of a greater understanding of the biology of both normal and malignant tissues.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ROLE OF ALPHA2,3 SIALYATED STRUCTURES IN MYELOPOIESIS
ROLE OF ALPHA2,3 SIALYATED STRUCTURES IN MYELOPOIESIS
ROLE OF ALPHA2,3 SIALYATED STRUCTURES IN MYELOPOIESIS
ROLE OF ALPHA2,3 SIALYATED STRUCTURES IN MYELOPOIESIS
海外基金